Detection of reproductive performance
Ewes failed to keep CIDR devices in the vagina were eliminated from our experiment (n=1 both in CIDR-based protocol groups). Statistics shown in Table 1 illustrate that the estrus rate (84.21%, 89.47%, 90%, respectively), pregnancy rate (47.37%, 63.16%, 65.00%, respectively), conception rate (56.25%, 70.59%, 72.22%, respectively), lambing rate (56.25%, 70.59%, 72.22%, respectively) of three treatment groups have no significant difference compared with control (75.00%, 60.00%, 80.00%, 80.00%, respectively). It is noted that even though the estrus rate between CIDR14+eCG (89.47%) and GnRH+PGF
2α (90.00%) were almost equal, the implement of intravaginal devices may trigger several problems, including the production of chemical residues and vaginitis that may threaten to female health, which encourage the usage of PGF
2α as an alternative, clean and safe for estrus synchronization.
Most notably, CIDR+PGF
2α+eCG and CIDR+eCG (145.78±1.56, 144.42±0.67, respectively) have significantly shorter (
P<0.05) duration of pregnancy than control (147.20±1.52), but GnRH+PGF
2α (146.31±1.55) has no effect on duration of pregnancy compared with control. Furthermore, CIDR+eCG (144.42±0.67) has shorter (
P<0.05) duration of pregnancy than the remaining treatment groups. This may due to the serum levels of P4 increased in CIDR-treated (14 days) ewes at 0 hour
(Swelum et al., 2015); The increasing P4 level during early pregnancy, which can decreases the lost of embryo and increases pregnancy rate and fertility
(Ataman et al., 2013). Therefore, during the later of pregnancy, there will not enough nutrition and space for the lamb to growth, which leading to shorter duration of pregnancy. With respect to fecundity, CIDR+eCG and GnRH+PGF
2α did not dramatically change the fecundity of ewes, while CIDR+PGF
2α+eCG significantly decreased (
P<0.05) the fecundity of that compared with the control.
Detection of estrus of various times
Effect of three treatments on percentage of ewes behaving estrus responses within various time of estrus detection post-treatment, 0-24 h, 24-48 h, 48-72 h, was descripted in Fig 2. It suggested that estrus responses in CIDR9+PGF
2α+eCG, CIDR14+eCG and GnRH+PGF
2α groups rose gradually to attain their significantly higher percentages (56.3%, 52.9% and 66.7%, respectively) during 24-48 h post-estrous detection, afterwards, they fell down. Besides, GnRH+PGF2a would cause the estrus cycle more synchronized and the estrus time is focused at the 24-48 hours after PGF
2α treatment with the estrus rate up to 66.7%. This in line with the results, reported by
Evans (1988),
Menchaca and Rubianes (2004),
Zeleke et al., (2005), that both the use of equine chorionic gonadotropin (eCG) and gonadotropin releasing hormone (GnRH) treatments could provide a more compact ovulation in ewes, thereby providing the potential to increase the pregnancy rates following AI in sheep. From the investigations on sheep folliculogenesis, it has been known that a follicle is in its active growing phase for the following four days to reach its maximum diameter at the fifth day after the insertion of a CIDR
(Martinez-Ros et al., 2018). It should be noted that the differences in size between dominant and subordinate follicles are very small and periods of effective dominance are very short
(Gonzalez-Bulnes et al., 2004). Furthermore, when sheep treated by GnRH+PGF
2α, the luteal tissue that forms as a result of the GnRH administration is responsive to PGF2
α and is capable of undergoing luteolysis (
Husein and Kridli, 2003). However, the response to GnRH is dependent upon the stage of the cycle at which it is administered. There have been reported that about half of the ewes had active corpora lutea at the time of GnRH administration
(Alminer et al., 2005; Titi et al., 2010). Accordingly, GnRH+PGF
2α-group appear to delay the phenomenon of ovulation, onset of oestrus.